PrescriptionDrugs.org

Lisdexamfetamine vs Atomoxetine

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Lisdexamfetamine (Vyvanse) and atomoxetine (Strattera) are both FDA-approved for attention-deficit/hyperactivity disorder (ADHD), but they represent fundamentally different approaches. Lisdexamfetamine is a prodrug stimulant (converted to dextroamphetamine in the body), while atomoxetine is a non-stimulant selective norepinephrine reuptake inhibitor.

This distinction matters for treatment selection. Stimulants like lisdexamfetamine are generally first-line for ADHD, but non-stimulants like atomoxetine are important alternatives for patients who cannot tolerate stimulants or have contraindications such as substance use history.

Lisdexamfetamine vs Atomoxetine: Side-by-side comparison

CategoryLisdexamfetamineAtomoxetine
Drug ClassStimulant (prodrug amphetamine)Non-stimulant (SNRI)
Brand NameVyvanseStrattera
DEA ScheduleSchedule IINot scheduled
Onset of EffectFirst day4-6 weeks for full effect
Duration10-14 hours24 hours (continuous)
Response Rate~70-80%~50-60%
Abuse PotentialLow (prodrug design)None
Helps AnxietyMay worsenMay improve

Efficacy: How well does each drug work?

Stimulants, including lisdexamfetamine, are considered the most effective ADHD medications. Clinical trials show lisdexamfetamine improves ADHD symptoms in approximately 70-80% of patients, with noticeable effects on the first day of treatment. Its prodrug design provides smooth, long-lasting symptom control for 10-14 hours.

Atomoxetine is effective but generally produces smaller symptom improvements than stimulants. Response rates are approximately 50-60%, and full effects take 4-6 weeks to develop. However, atomoxetine provides continuous 24-hour coverage since it is taken daily and builds up in the system.

Atomoxetine may be particularly useful for patients with comorbid anxiety, as it can improve both ADHD and anxiety symptoms, whereas stimulants can sometimes worsen anxiety.

Side effects comparison

Lisdexamfetamine's common side effects include decreased appetite, insomnia, dry mouth, increased heart rate, and potential for mood changes. As a Schedule II controlled substance, it carries a risk of misuse and dependence, though the prodrug mechanism reduces abuse potential compared to immediate-release amphetamines.

Atomoxetine is not a controlled substance and has no abuse potential. Common side effects include nausea, decreased appetite, fatigue, and stomach upset. It carries an FDA boxed warning for increased suicidal thinking in children and adolescents, requiring close monitoring during initial treatment.

Both drugs can increase heart rate and blood pressure. Cardiovascular screening is recommended before starting either medication.

Cost comparison

Brand-name Vyvanse has been expensive historically ($300-$400/month), but generic lisdexamfetamine became available in 2023, significantly reducing costs. Generic atomoxetine has been available for years and typically costs $30-$80 per month.

Insurance coverage for both is generally good, though some plans may require prior authorization or step therapy (trying one medication class before the other).

Convenience and dosing

Lisdexamfetamine is taken once daily in the morning. Its prodrug design means it cannot be snorted or injected for a rapid high, which reduces diversion risk. Effects last 10-14 hours, covering the school or work day.

Atomoxetine is taken once or twice daily and provides 24-hour coverage, which can help with early morning and evening symptoms. It does not require DEA prescribing restrictions, making refills easier — no need for new paper prescriptions each month in many states.

Which is right for you?

Stimulants like lisdexamfetamine are the first-line treatment for ADHD in most guidelines. If you have straightforward ADHD without complicating factors, lisdexamfetamine or another stimulant is likely the most effective starting point.

Atomoxetine is a strong alternative if you have a history of substance use disorders, significant anxiety alongside ADHD, intolerable stimulant side effects, or concerns about controlled substance scheduling. It is also the preferred option in some military and occupational settings where stimulant use is restricted.

Some patients who do not respond adequately to one class may respond to the other, or may benefit from combination therapy under specialist guidance. Work with your prescriber to find the best approach.

Frequently asked questions

References

  1. [Observational] Vyvanse (lisdexamfetamine) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021977s045lbl.pdf Accessed 2026-03-01.
  2. [Observational] Strattera (atomoxetine) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021411s048lbl.pdf Accessed 2026-03-01.
  3. [Observational] ADHD Treatment Guidelines - AAP https://pubmed.ncbi.nlm.nih.gov/31570648/ Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: